Cargando…
Characterization of health concerns in people with neurofibromatosis type 1
BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834143/ https://www.ncbi.nlm.nih.gov/pubmed/36444392 http://dx.doi.org/10.1002/mgg3.2077 |
_version_ | 1784868396217663488 |
---|---|
author | Fleming, Jane Morgan, Oliver Wong, Claire Schlub, Timothy E. Berman, Yemima |
author_facet | Fleming, Jane Morgan, Oliver Wong, Claire Schlub, Timothy E. Berman, Yemima |
author_sort | Fleming, Jane |
collection | PubMed |
description | BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a population cohort. METHODS: An online survey was completed by 68 adults and 32 parents of children with NF1, and 60 controls. The survey included the Skindex‐29 QOL scale, 5D‐itch scale, and additional health questions. RESULTS: Frequency of itch was high in children (50%) and adults (69%), with most expressing interest in treatment for itch. The presence of itch and increased visibility of NF1 were predictors of poorer QoL. Many adults (53%) and parents (44%) desired access to treatment to improve cosmetic appearance. Muscle weakness/tiredness was also prevalent amongst (60–70%) adults and children with NF1. Two‐thirds of adults with NF1 reported limited awareness of NF1 services and poor knowledge of surveillance, particularly breast screening in young women. CONCLUSION: This study highlights the impact of NF1‐related itch and visibility in adults and children with a need for cosmetic and itch treatment. The findings emphasize a need for strategies to promote awareness, and access to management and treatment of NF1 in adults. |
format | Online Article Text |
id | pubmed-9834143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98341432023-01-13 Characterization of health concerns in people with neurofibromatosis type 1 Fleming, Jane Morgan, Oliver Wong, Claire Schlub, Timothy E. Berman, Yemima Mol Genet Genomic Med Original Articles BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a population cohort. METHODS: An online survey was completed by 68 adults and 32 parents of children with NF1, and 60 controls. The survey included the Skindex‐29 QOL scale, 5D‐itch scale, and additional health questions. RESULTS: Frequency of itch was high in children (50%) and adults (69%), with most expressing interest in treatment for itch. The presence of itch and increased visibility of NF1 were predictors of poorer QoL. Many adults (53%) and parents (44%) desired access to treatment to improve cosmetic appearance. Muscle weakness/tiredness was also prevalent amongst (60–70%) adults and children with NF1. Two‐thirds of adults with NF1 reported limited awareness of NF1 services and poor knowledge of surveillance, particularly breast screening in young women. CONCLUSION: This study highlights the impact of NF1‐related itch and visibility in adults and children with a need for cosmetic and itch treatment. The findings emphasize a need for strategies to promote awareness, and access to management and treatment of NF1 in adults. John Wiley and Sons Inc. 2022-11-28 /pmc/articles/PMC9834143/ /pubmed/36444392 http://dx.doi.org/10.1002/mgg3.2077 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Fleming, Jane Morgan, Oliver Wong, Claire Schlub, Timothy E. Berman, Yemima Characterization of health concerns in people with neurofibromatosis type 1 |
title | Characterization of health concerns in people with neurofibromatosis type 1 |
title_full | Characterization of health concerns in people with neurofibromatosis type 1 |
title_fullStr | Characterization of health concerns in people with neurofibromatosis type 1 |
title_full_unstemmed | Characterization of health concerns in people with neurofibromatosis type 1 |
title_short | Characterization of health concerns in people with neurofibromatosis type 1 |
title_sort | characterization of health concerns in people with neurofibromatosis type 1 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834143/ https://www.ncbi.nlm.nih.gov/pubmed/36444392 http://dx.doi.org/10.1002/mgg3.2077 |
work_keys_str_mv | AT flemingjane characterizationofhealthconcernsinpeoplewithneurofibromatosistype1 AT morganoliver characterizationofhealthconcernsinpeoplewithneurofibromatosistype1 AT wongclaire characterizationofhealthconcernsinpeoplewithneurofibromatosistype1 AT schlubtimothye characterizationofhealthconcernsinpeoplewithneurofibromatosistype1 AT bermanyemima characterizationofhealthconcernsinpeoplewithneurofibromatosistype1 |